Pharmaceuticals Clinical Trials Drug Development Gene Therapy Immunotherapy Cell Therapy Oncology Regulatory Affairs Therapies Vaccines Rare Diseases Drug Discovery Gene Editing Research and Development Therapeutics Product Development Pharmaceutical Companies Biologics Moderna Biotech Companies Insulin Products Drug Delivery RNA Interference Theranos Innovation Biosimilars Complement Inhibitors Acquisitions Genmab Immunotherapeutics Bioinformatics Asset Tokenization Obesity Treatment Corporate Actions Drug Companies Market Competition Contract Manufacturing AI in Medicine Bioprocessing Viking Therapeutics Genetic Medicine Gene Sequencing Clinical Research Company Announcements Genetics Regulatory Compliance Humacyte, Inc. Medical Devices Company Operations Market Trends Genetic Testing Bluebird bio Inc. Companies Contract Research Organizations Diagnostics
The firm credits disciplined stock selection with tactical reallocations as the key drivers.
